# Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work Productivity

> **NCT05132231** · — · ACTIVE_NOT_RECRUITING · sponsor: **Bausch Health Americas, Inc.** · enrollment: 394 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **BIOLOGICAL:** Brodalumab
- **BIOLOGICAL:** Matched cohort

## Key facts

- **NCT ID:** NCT05132231
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-10-22
- **Primary completion:** 2025-02-05
- **Final completion:** 2026-03-31
- **Target enrollment:** 394 (ACTUAL)
- **Last updated:** 2025-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05132231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05132231, "Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work Productivity". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05132231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*